ArticleCancer science2017

Carfilzomib, lenalidomide and dexamethasone in patients with heavily pretreated multiple myeloma: A phase 1 study in Japan.

Kenshi Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.